| OTC Markets: AHRO
Similar to: EpiStem Holdings Plc
AtheroNova, Inc. is a biopharmaceutical company focused on the discovery, research, development and licensing of novel compounds designed to reduce or eliminate atherosclerotic plaque deposits. The company operates through its wholly-owned subsidiary, AtheroNova Operations, Inc. a development stage company. AtheroNova is currently conducting two additional animal studies to validate the findings of its initial study and prepare for human trials. It was founded in 1997 and is headquartered in Irvine, CA.